论文部分内容阅读
We propose a dynamic network model for the evolution of an open animal population that is subject to an environmental catastrophe.
Sequential Monte Carlo of dynamic network for animal population estimation
【摘 要】
：
We propose a dynamic network model for the evolution of an open animal population that is subject to an environmental catastrophe.
【机 构】
：
School of Mathematics & Statistics,The University of Melbourne,VIC 3010,Australia
【出 处】
：
上海交通大学
【发表日期】
：
2016年4期
其他文献
Array-based CGH experiments are designed to detect genomic aberrations or regions of DNA copy-number variation that are associated with an outcome,typically a state of disease.
How Genes Coordinate Competition and Cooperation:New Insight by Integrating Functional Mapping and E
The identification of genes determining spatial-temporal changes of ecological interactions is of paramount importance for ecological and evolutionary research.
A new framework of statistical inferences based on the valid joint sampling distribution of the obse
Some existing confidence interval methods and hypothesis testing methods in the analysis of a contingency table with incomplete observations in both margins entirely depend on an underlying assumption
会议
Although complete randomization ensures covariate balance on average,the chance for observing significant differences between treatment and control covariate distributions is high especially with many
We consider the problem associated to recovering the block structure of an Ising model given independent observations on the binary hypercube.
Testing for white noise is a classical yet important problem in statistics,especially for diagnostic checks in time series modeling.
This talk discusses the average value-at-risk(AVaR)criterion for finite horizon semi-Markov decision processes(SMDPs)in continuous-time.
In this talk,I will give some kinds of risk model with dependence structure,and some criteria under which we discuss the optimization problems.
Data Science programs,including academic,professional,short course and boot-camps,now abound worldwide.
As the treatments for breast cancer improve,disease free survival time is extensively prolonged and pharmaceutical developer faces a new challenge in clinical trial design and conduct based on long te
会议